Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Genes Chromosomes Cancer
    February 2018
  1. FIMERELI D, Fumagalli D, Brown D, Gacquer D, et al
    Genomic hotspots but few recurrent fusion genes in breast cancer.
    Genes Chromosomes Cancer. 2018 Feb 13. doi: 10.1002/gcc.22533.
    >> Share

    November 2017
  2. OLTMANN J, Heselmeyer-Haddad K, Hernandez LS, Meyer R, et al
    Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.
    Genes Chromosomes Cancer. 2017 Nov 27. doi: 10.1002/gcc.22515.
    >> Share

    September 2017
  3. WANG X, Teer JK, Tousignant RN, Levin AM, et al
    Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.
    Genes Chromosomes Cancer. 2017 Sep 10. doi: 10.1002/gcc.22503.
    >> Share

    July 2017
  4. BUBIEN V, Bonnet F, Dupiot-Chiron J, Barouk-Simonet E, et al
    Combined tumor genomic profiling and exome sequencing in a breast cancer family implicates ATM in tumorigenesis: a proof of principle study.
    Genes Chromosomes Cancer. 2017 Jul 10. doi: 10.1002/gcc.22482.
    >> Share

    June 2017
  5. KULKARNI S, Bill A, Godse NR, Khan NI, et al
    TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
    Genes Chromosomes Cancer. 2017;56:460-471.
    >> Share

    April 2017
  6. SUN H, Liu T, Zhu D, Dong X, et al
    HnRNPM and CD44s expression affects tumor aggressiveness and predicts poor prognosis in breast cancer with axillary lymph node metastases.
    Genes Chromosomes Cancer. 2017 Apr 10. doi: 10.1002/gcc.22463.
    >> Share

    March 2017
  7. FEJZO MS, Anderson L, Chen HW, Guandique E, et al
    Proteasome Ubiquitin Receptor PSMD4 is an Amplification Target in Breast Cancer and May Predict Sensitivity to PARPi.
    Genes Chromosomes Cancer. 2017 Mar 18. doi: 10.1002/gcc.22459.
    >> Share

    October 2016
  8. PFARR N, Penzel R, Endris V, Lier C, et al
    Targeted Next Generation Sequencing Enables Reliable Detection of HER2 (ERBB2) Status in Breast Cancer and Provides Ancillary Information of Clinical Relevance.
    Genes Chromosomes Cancer. 2016 Oct 28. doi: 10.1002/gcc.22431.
    >> Share

    September 2016
  9. DAMIANO V, Brisotto G, Borgna S, di Gennaro A, et al
    Epigenetic Silencing of miR-200c in Breast Cancer Is Associated with Aggressiveness and Is Modulated by ZEB1.
    Genes Chromosomes Cancer. 2016 Sep 22. doi: 10.1002/gcc.22422.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016